VolitionRX LtdNYSE American:VNRX
- LAST PRICE0.6636
- TODAY'S CHANGE (%)-0.0164 (-2.4118%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.6500 / 0.6800
- Day Range
- 52 Week Range
- Volume97,477
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VNRX |
|---|---|---|
| 09:32 ET | 8624 | 0.65 |
| 09:44 ET | 1249 | 0.67 |
| 09:50 ET | 1173 | 0.6778 |
| 09:51 ET | 150 | 0.65 |
| 09:55 ET | 100 | 0.68 |
| 10:04 ET | 100 | 0.68 |
| 10:11 ET | 100 | 0.68 |
| 10:13 ET | 3000 | 0.65 |
| 10:20 ET | 100 | 0.6798 |
| 10:22 ET | 1152 | 0.67952 |
| 10:27 ET | 400 | 0.65 |
| 10:29 ET | 100 | 0.6798 |
| 10:36 ET | 5000 | 0.68 |
| 10:38 ET | 100 | 0.6798 |
| 10:47 ET | 100 | 0.6798 |
| 10:51 ET | 2286 | 0.68 |
| 10:56 ET | 140 | 0.675 |
| 10:58 ET | 100 | 0.69 |
| 11:07 ET | 100 | 0.699 |
| 11:18 ET | 100 | 0.7 |
| 11:20 ET | 2855 | 0.6727 |
| 11:27 ET | 4000 | 0.69 |
| 11:41 ET | 13373 | 0.6767 |
| 11:43 ET | 100 | 0.675 |
| 11:52 ET | 300 | 0.68 |
| 12:06 ET | 500 | 0.68 |
| 12:24 ET | 20100 | 0.67 |
| 12:32 ET | 100 | 0.68 |
| 12:44 ET | 3700 | 0.6611 |
| 12:53 ET | 100 | 0.68 |
| 01:06 ET | 100 | 0.679 |
| 01:20 ET | 100 | 0.68 |
| 01:31 ET | 100 | 0.68 |
| 01:58 ET | 100 | 0.68 |
| 02:12 ET | 1286 | 0.6677 |
| 02:16 ET | 795 | 0.67 |
| 02:18 ET | 1407 | 0.67 |
| 02:23 ET | 510 | 0.67 |
| 02:38 ET | 100 | 0.67 |
| 03:01 ET | 100 | 0.6759 |
| 03:06 ET | 500 | 0.6759 |
| 03:12 ET | 100 | 0.6759 |
| 03:14 ET | 3877 | 0.6729 |
| 03:15 ET | 2300 | 0.674 |
| 03:17 ET | 400 | 0.6718 |
| 03:19 ET | 2000 | 0.6722 |
| 03:21 ET | 100 | 0.6722 |
| 03:24 ET | 800 | 0.672 |
| 03:32 ET | 1768 | 0.679 |
| 03:42 ET | 100 | 0.676 |
| 03:48 ET | 100 | 0.68 |
| 03:50 ET | 500 | 0.68 |
| 03:51 ET | 100 | 0.68 |
| 03:53 ET | 391 | 0.68 |
| 03:55 ET | 100 | 0.68 |
| 03:57 ET | 2088 | 0.68 |
| 04:00 ET | 1913 | 0.6636 |
Nov 15, 2024
DJ VolitionRX Is Maintained at Buy by D. Boral Capital, from 5:05PM ET on Friday Nov 15, 2024 by Dow Jones
5:05PM ET on Friday Nov 15, 2024 by Dow Jones
Nov 14, 2024
*DJ VolitionRX 3Q Rev $475,000 >VNRX, from 4:24PM ET on Thursday Nov 14, 2024 by Dow Jones
4:24PM ET on Thursday Nov 14, 2024 by Dow JonesVolitionRx Limited Announces Third Quarter 2024 Financial Results and Business Update, from 4:10PM ET on Thursday Nov 14, 2024 by Dow Jones
4:10PM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 8, 2024
VolitionRx Limited Schedules Third Quarter 2024 Earnings Conference Call and Business Update, from 8:00AM ET on Friday Nov 08, 2024 by Dow Jones
8:00AM ET on Friday Nov 08, 2024 by Dow Jones
Nov 6, 2024
Volition Appoints Timothy I. Still as Chairman, from 4:10PM ET on Wednesday Nov 06, 2024 by Dow Jones
4:10PM ET on Wednesday Nov 06, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
VolitionRX Ltd | 62.6M | -1.8x | --- |
RetinalGenix Technologies Inc | 63.0M | -15.3x | --- |
Aileron Therapeutics Inc | 62.2M | -0.9x | --- |
Entera Bio Ltd | 63.7M | -6.4x | --- |
Connect Biopharma Holdings Ltd | 61.3M | -2.6x | --- |
Allovir Inc | 65.7M | -0.7x | --- |
Company Information
VolitionRx Limited is a multi-national epigenetics company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.
Contact Information
- Headquarters
- 1489 West Warm Springs Road, Suite 110HENDERSON, NV, United States 89014
- Phone
- 646-650-1351
- Fax
- ---
Executives
- Non-Executive Chairman of the Board
- Timothy Still
- President, Chief Executive Officer, Director
- Cameron Reynolds
- Chief Financial Officer, Treasurer
- Terig Hughes
- Chief Executive Officer of Volition Vet
- Salvatore Butera
- Chief Executive Officer of Singapore Volition
- Jasmine Kway
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $61.1M |
|---|---|
Revenue (TTM) | $1.3M |
Shares Outstanding | 92.1M |
VolitionRX Ltd does not pay a dividend. | |
Beta | 1.14 |
EPS | $-0.36 |
Book Value | $-0.10 |
P/E Ratio | -1.8x |
Price/Sales (TTM) | 47.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -2,331.90% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
